Cassava Sciences rebrands to Filana Therapeutics (FLNA) on March 11, 2026, focusing on filamin A CNS therapies for TSC epilepsy—get the latest update.

New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in treating ...

Filana Therapeutics, Inc. (formerly Cassava Sciences, Inc.) (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company focused on developing novel medicines to modulate the filamin ...

Weis Markets Inc (WMK) is expected to report for 4Q. Yext Inc (YEXT) is expected to report $0.06 for 4Q. Zenas BioPharma Inc (ZBIO) is expected to report for 4Q. enCore Energy Corp (EU.V) is expected ...

Filana Therapeutics Inc. research and ratings by Barron's. View FLNA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Sugar cane (Saccharum officinarum), a tropical perennial grass native to Papua New Guinea and Southeast Asia, is one of the world’s most important economic food and energy crops. Its soaring stalks ...

Two Manchester researchers, Professor Bruce Grieve and Professor Hujun Yin, were recognised with the Pioneering UK-US Breakthroughs (PUB) award, by the UK Research and Innovation in the British ...

Global carbon budgets attribute an incomplete role to cultivated plants due to the exclusion of annual crops, since they are not considered to result in net carbon accum ...

Climate change remains a great challenge to rural livelihoods in Sierra Leone, especially in agricultural communities that depend on climate-sensitive resources. Although indigenous knowledge has been ...

As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The ...